Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2077358983', 'doi': 'https://doi.org/10.7326/0003-4819-151-9-200911030-00013', 'title': 'Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?', 'display_name': 'Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?', 'publication_year': 2009, 'publication_date': '2009-11-03', 'ids': {'openalex': 'https://openalex.org/W2077358983', 'doi': 'https://doi.org/10.7326/0003-4819-151-9-200911030-00013', 'mag': '2077358983', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19884628'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/0003-4819-151-9-200911030-00013', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5044831604', 'display_name': 'Maarten Boers', 'orcid': 'https://orcid.org/0000-0002-6969-283X'}, 'institutions': [{'id': 'https://openalex.org/I911458345', 'display_name': 'Amsterdam UMC Location VUmc', 'ror': 'https://ror.org/00q6h8f30', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210151833', 'https://openalex.org/I911458345']}], 'countries': ['NL'], 'is_corresponding': True, 'raw_author_name': 'Maarten Boers', 'raw_affiliation_strings': ['From VU University Medical Center, Amsterdam, the Netherlands.'], 'affiliations': [{'raw_affiliation_string': 'From VU University Medical Center, Amsterdam, the Netherlands.', 'institution_ids': ['https://openalex.org/I911458345']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5044831604'], 'corresponding_institution_ids': ['https://openalex.org/I911458345'], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 14, 'citation_normalized_percentile': {'value': 0.720994, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '151', 'issue': '9', 'first_page': '668', 'last_page': '668'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12255', 'display_name': 'Immunogenicity of Biosimilar Therapeutics in Drug Development', 'score': 0.9925, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10308', 'display_name': 'Systemic Lupus Erythematosus and Antiphospholipid Syndrome', 'score': 0.9866, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/window-of-opportunity', 'display_name': 'Window of opportunity', 'score': 0.58851755}, {'id': 'https://openalex.org/keywords/rheumatoid-arthritis', 'display_name': 'Rheumatoid Arthritis', 'score': 0.492923}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9628652}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.8684519}, {'id': 'https://openalex.org/C2778363899', 'wikidata': 'https://www.wikidata.org/wiki/Q23900955', 'display_name': 'Window of opportunity', 'level': 2, 'score': 0.58851755}, {'id': 'https://openalex.org/C2777077863', 'wikidata': 'https://www.wikidata.org/wiki/Q170990', 'display_name': 'Arthritis', 'level': 2, 'score': 0.54029834}, {'id': 'https://openalex.org/C2909063479', 'wikidata': 'https://www.wikidata.org/wiki/Q810254', 'display_name': 'Antirheumatic Agents', 'level': 3, 'score': 0.4460592}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.44113475}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.42942798}, {'id': 'https://openalex.org/C79403827', 'wikidata': 'https://www.wikidata.org/wiki/Q3988', 'display_name': 'Real-time computing', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000191', 'qualifier_name': 'economics', 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003362', 'descriptor_name': 'Cost-Benefit Analysis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000191', 'qualifier_name': 'economics', 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/0003-4819-151-9-200911030-00013', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19884628', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.88, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 9, 'referenced_works': ['https://openalex.org/W1953534612', 'https://openalex.org/W1967020676', 'https://openalex.org/W1982063326', 'https://openalex.org/W1991000304', 'https://openalex.org/W1994955363', 'https://openalex.org/W2101964061', 'https://openalex.org/W2147355996', 'https://openalex.org/W2156712409', 'https://openalex.org/W2340455003'], 'related_works': ['https://openalex.org/W3021018229', 'https://openalex.org/W2979207018', 'https://openalex.org/W2411685755', 'https://openalex.org/W2376277633', 'https://openalex.org/W2352867790', 'https://openalex.org/W2186134304', 'https://openalex.org/W2133093927', 'https://openalex.org/W2016776057', 'https://openalex.org/W2016261626', 'https://openalex.org/W1988363007'], 'abstract_inverted_index': {'Editorials3': [0], 'November': [1, 684, 698, 703], '2009Cost-Effectiveness': [2], 'of': [3, 8, 61, 71, 75, 85, 88, 97, 101, 152, 184, 240, 324, 349, 512, 537, 582, 599, 612, 617, 626, 663, 694, 711], 'Biologics': [4, 583, 600, 664], 'as': [5], 'First-Line': [6], 'Treatment': [7, 145, 239, 422], 'Rheumatoid': [9, 46, 540, 586, 603, 667], 'Arthritis:': [10], 'Case': [11], 'Closed?Maarten': [12], 'Boers,': [13, 17, 507], 'MSc,': [14, 18, 508], 'MD,': [15, 19, 509, 670, 679], 'PhDMaarten': [16], 'PhDFrom': [20], 'VU': [21, 478, 516], 'University': [22, 479, 517], 'Medical': [23, 480, 518], 'Center,': [24, 481, 519], 'Amsterdam,': [25, 482, 527], 'The': [26, 83, 110, 483], 'Netherlands.Search': [27], 'for': [28, 208, 288, 292, 380, 624, 660], 'more': [29], 'papers': [30], 'by': [31, 55, 708], 'this': [32], 'authorAuthor,': [33], 'Article,': [34, 473], 'and': [35, 80, 91, 121, 129, 141, 391, 426, 474, 514, 577, 594, 631, 637, 675, 692], 'Disclosure': [36, 475], 'Informationhttps://doi.org/10.7326/0003-4819-151-9-200911030-00013': [37], 'SectionsAboutFull': [38], 'TextPDF': [39], 'ToolsAdd': [40], 'to': [41, 67, 134, 651], 'favoritesDownload': [42], 'CitationsTrack': [43], 'CitationsPermissions': [44], 'ShareFacebookTwitterLinkedInRedditEmail': [45], 'arthritis': [47, 158, 244, 641], '(RA)': [48], 'is': [49], 'an': [50, 455], 'autoimmune,': [51], 'multisystem': [52], 'disease': [53], 'characterized': [54], 'chronic': [56], 'inflammation': [57], 'and,': [58], 'ultimately,': [59], 'destruction': [60], 'joints.': [62], 'Left': [63], 'unchecked,': [64], 'it': [65], 'leads': [66], 'a': [68, 86, 191, 215, 286, 289, 394, 618, 644], 'high': [69], 'burden': [70], 'disease,': [72], 'early': [73, 90, 107, 156, 188, 242, 383], 'loss': [74], 'work': [76], 'capacity,': [77], 'major': [78], 'morbidity,': [79], 'increased': [81], 'mortality.': [82], 'concept': [84, 154], 'window': [87, 151], 'opportunity—that': [89], 'aggressive': [92], 'treatment': [93, 185, 325, 625], 'could': [94], 'prevent': [95], 'many': [96], 'the': [98, 102, 106, 139, 142, 150, 528, 610, 633], 'long-term': [99], 'consequences': [100], 'disease—was': [103], 'introduced': [104], 'in': [105, 125, 137, 155, 187, 212, 295, 327, 354, 429, 459, 584, 601, 639, 665], '1990s': [108], '(1).': [109], 'drugs': [111, 119], 'available': [112], 'at': [113], 'that': [114], 'time,': [115], 'including': [116], 'disease-modifying': [117, 248, 389], 'antirheumatic': [118, 249], '(DMARDs)': [120], 'glucocorticoids,': [122], 'were': [123], 'tested': [124], 'different': [126], 'combination': [127], 'strategies': [128, 133, 186, 326], 'proven': [130], 'through': [131], 'tight-control': [132], 'be': [135], 'effective': [136], 'both': [138], 'short': [140], 'long': [143], 'term.': [144], '...References1.': [146], 'Boers': [147, 202, 269, 344, 442, 486, 494, 606], 'M.': [148, 203, 485, 493], 'Understanding': [149], 'opportunity': [153], 'rheumatoid': [157, 189, 213, 243, 296, 331, 355, 385, 432, 460, 627, 640, 648], '[Editorial].': [159], 'Arthritis': [160, 218, 333, 465, 541, 587, 604], 'Rheum.': [161, 219, 334, 466], '2003;48:1771-4.': [162], '[PMID:': [163, 198, 221, 301, 336, 362, 404, 438, 468], '12847667]': [164], 'CrossrefMedlineGoogle': [165, 223, 338, 440, 470], 'Scholar2.': [166], 'Goekoop-Ruiterman': [167, 309], 'YP,': [168, 310], 'de': [169, 313], 'Vries-Bouwstra': [170, 314], 'JK,': [171, 315], 'Allaart': [172, 311], 'CF,': [173, 312], 'van': [174, 305, 366], 'Zeben': [175], 'D,': [176, 272], 'Kerstens': [177, 318], 'PJ,': [178, 319], 'Hazes': [179, 316], 'JM,': [180, 317], 'et': [181, 237, 275, 320, 420], 'al.': [182, 238, 321, 421], 'Comparison': [183], 'arthritis:': [190, 214, 386, 461, 628], 'randomized': [192], 'trial.': [193, 399], 'Ann': [194, 257, 400, 434], 'Intern': [195, 258, 401], 'Med.': [196, 259, 402], '2007;146:406-15.': [197], '17371885]': [199], 'LinkGoogle': [200, 261, 406], 'Scholar3.': [201], 'Add-on': [204], 'or': [205, 251, 548], 'step-up': [206], 'trials': [207, 659], 'new': [209, 216, 645], 'drug': [210], 'development': [211], 'standard?': [217], '2003;48:1481-3.': [220], '12794813]': [222], 'Scholar4.': [224], 'Finckh': [225, 552, 589], 'A,': [226, 268], 'Bansback': [227, 555, 592], 'N,': [228], 'Marra': [229, 559], 'CA,': [230], 'Anis': [231, 563], 'AH,': [232], 'Michaud': [233, 566], 'K,': [234], 'Lubin': [235, 569], 'S,': [236, 264, 447], 'very': [241], 'with': [245, 329, 382, 423, 431], 'symptomatic': [246], 'therapy,': [247], 'drugs,': [250], 'biologic': [252, 646], 'agents.': [253], 'A': [254], 'cost-effectiveness': [255], 'analysis.': [256], '2009;151:612-21.': [260], 'Scholar5.': [262], 'Gabriel': [263, 446], 'Drummond': [265], 'M,': [266, 270, 345, 443], 'Maetzel': [267], 'Coyle': [271], 'Welch': [273], 'V,': [274], 'al;': [276], 'Patient': [277], 'Perspective': [278], 'Group.': [279], 'OMERACT': [280], '6': [281], 'Economics': [282], 'Working': [283], 'Group': [284], 'report:': [285], 'proposal': [287], 'reference': [290], 'case': [291], 'economic': [293], 'evaluation': [294], 'arthritis.': [297, 332, 356, 433], 'J': [298], 'Rheumatol.': [299], '2003;30:886-90.': [300], '12672223]': [302], 'MedlineGoogle': [303, 364], 'Scholar6.': [304], 'den': [306], 'Hout': [307], 'WB,': [308], 'Cost-utility': [322], 'analysis': [323], 'patients': [328, 381, 430], 'recent-onset': [330], '2009;61:291-9.': [335], '19248130]': [337], 'Scholar7.': [339], 'Kirwan': [340], 'JR,': [341], 'Bijlsma': [342, 375], 'JW,': [343, 370], 'Shea': [346], 'BJ.': [347], 'Effects': [348], 'glucocorticoids': [350], 'on': [351, 457], 'radiological': [352], 'progression': [353], 'Cochrane': [357], 'Database': [358], 'Syst': [359], 'Rev.': [360], '2007;:CD006356.': [361], '17253590]': [363], 'Scholar8.': [365], 'Everdingen': [367], 'AA,': [368], 'Jacobs': [369], 'Siewertsz': [371], 'Van': [372], 'Reesema': [373], 'DR,': [374], 'JW.': [376], 'Low-dose': [377], 'prednisone': [378], 'therapy': [379], 'active': [384], 'clinical': [387, 398, 658], 'efficacy,': [388], 'properties,': [390], 'side': [392], 'effects:': [393], 'randomized,': [395], 'double-blind,': [396], 'placebo-controlled': [397], '2002;136:1-12.': [403], '11777359]': [405], 'Scholar9.': [407], 'Jacobsson': [408], 'LT,': [409], 'Turesson': [410], 'C,': [411], 'Nilsson': [412], 'JA,': [413], 'Petersson': [414], 'IF,': [415], 'Lindqvist': [416], 'E,': [417], 'Saxne': [418], 'T,': [419], 'TNF': [424], 'blockers': [425], 'mortality': [427, 458], 'risk': [428], 'Rheum': [435], 'Dis.': [436], '2007;66:670-5.': [437], '17158824]': [439], 'Scholar10.': [441], 'Dijkmans': [444], 'B,': [445], 'Maradit-Kremers': [448], 'H,': [449], "O'Dell": [450], 'J,': [451], 'Pincus': [452], 'T.': [453], 'Making': [454], 'impact': [456], 'targeting': [462, 647], 'cardiovascular': [463], 'comorbidity.': [464], '2004;50:1734-9.': [467], '15188348]': [469], 'Scholar': [471], 'Author,': [472], 'InformationAffiliations:': [476], 'From': [477], 'Netherlands.Disclosures:Consultancies:': [484], '(Roche,': [487], 'Nitec,': [488], 'Mapi': [489], 'Values,': [490], 'GlaxoSmithKline).': [491], 'Honoraria:': [492], '(Sanofi,': [495], 'Novartis,': [496], 'Merck,': [497], 'Astra,': [498], 'Nicox,': [499], 'Savient,': [500], 'Combinatorx,': [501], 'Astellas': [502], 'MedImmune,': [503], 'Schering-Plough).Corresponding': [504], 'Author:': [505], 'Maarten': [506, 605], 'PhD,': [510], 'Department': [511], 'Epidemiology': [513], 'Biostatistics,': [515], 'PK': [520], '6Z': [521], '185,': [522], 'Box': [523], '7057,': [524], '1007': [525], 'MB,': [526], 'Netherlands;': [529], 'e-mail,': [530], '[email': [531], 'protected]nl.': [532], 'PreviousarticleNextarticle': [533], 'Advertisement': [534], 'FiguresReferencesRelatedDetailsSee': [535], 'AlsoTreatment': [536], 'Very': [538], 'Early': [539, 585, 602, 666], 'With': [542], 'Symptomatic': [543], 'Therapy,': [544], 'Disease-Modifying': [545], 'Antirheumatic': [546], 'Drugs,': [547], 'Biologic': [549], 'Agents': [550], 'Axel': [551, 588], ',': [553, 556, 560, 564, 567, 570, 573, 576, 590, 593], 'Nick': [554, 591, 672], 'Carlo': [557], 'A.': [558], 'Aslam': [561], 'H.': [562, 579, 596, 677], 'Kaleb': [565], 'Stanley': [568], 'Marc': [571], 'White': [572], 'Sonia': [574], 'Sizto': [575], 'Matthew': [578, 595, 676], 'Liang': [580, 597], 'Cost-Effectiveness': [581, 598], 'Metrics': [607], 'Cited': [608], 'ByMeasuring': [609], 'bioactivity': [611], 'anti-IL-6/anti-IL-6R': [613], 'therapeutic': [614, 681], 'antibodies:': [615], 'presentation': [616], 'robust': [619], 'reporter': [620], 'gene': [621], 'assayIL-6': [622], 'inhibitors': [623], 'past,': [629], 'present,': [630], 'futureRethinking': [632], 'discordance': [634], 'between': [635], 'guidelines': [636], 'practice': [638], 'treatmentEditorialCertolizumab': [642], 'pegol:': [643], 'arthritisNovel': [649], 'approaches': [650], 'incorporating': [652], 'pharmacoeconomic': [653], 'studies': [654], 'into': [655], 'phase': [656], 'III': [657], "Alzheimer's": [661], 'diseaseCost-Effectiveness': [662], 'ArthritisAxel': [668], 'Finckh,': [669], 'MS,': [671, 674], 'Bansback,': [673], 'Liang,': [678], 'MPHDevolving': [680], 'pyramids': [682], '3': [683, 697, 702], '2009Volume': [685], '151,': [686], 'Issue': [687, 700], '9Page:': [688], '668-669KeywordsDrugsGlucocorticoid': [689], 'therapyInformation': [690], 'storage': [691], 'retrievalNSAIDsQuality': [693], 'life': [695], 'ePublished:': [696], '2009': [699, 704, 707], 'Published:': [701], 'CopyrightCopyright': [705], '©': [706], 'American': [709], 'College': [710], 'Physicians.': [712], 'All': [713], 'Rights': [714], 'Reserved.PDF': [715], 'DownloadLoading': [716], '...': [717]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2077358983', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-09-08T22:27:33.161773', 'created_date': '2016-06-24'}